Genre
Galaxy is a 'Frankenstein'
A seemingly nondescript galaxy is actually a behemoth cobbled together out of various cosmic spare parts, Frankenstein-style, a new study suggests. UGC 1382, which lies about 250 million light-years from Earth, had long been regarded as an old, small and ordinary elliptical galaxy. But new observations show that it's actually a spiral, 718,000 light-years wide -- seven times larger than Earth's own Milky Way. "The center of UGC 1382 is actually younger than the spiral disk surrounding it," study co-author Mark Seibert, of the Observatories of the Carnegie Institution for Science in Pasadena, California, said in a statement. This is like finding a tree whose inner growth rings are younger than the outer rings."
Sky Q to get free 4K channels, ready for the start of the Premier League
Nasa has announced that it has found evidence of flowing water on Mars. Scientists have long speculated that Recurring Slope Lineae -- or dark patches -- on Mars were made up of briny water but the new findings prove that those patches are caused by liquid water, which it has established by finding hydrated salts. Several hundred camped outside the London store in Covent Garden. The 6s will have new features like a vastly improved camera and a pressure-sensitive "3D Touch" display
Microsoft opts out of Gamescom 2016 press conference in favour of small fan event
Nasa has announced that it has found evidence of flowing water on Mars. Scientists have long speculated that Recurring Slope Lineae -- or dark patches -- on Mars were made up of briny water but the new findings prove that those patches are caused by liquid water, which it has established by finding hydrated salts. Several hundred camped outside the London store in Covent Garden. The 6s will have new features like a vastly improved camera and a pressure-sensitive "3D Touch" display
Billionaire Mike Lynch explains why he's putting his money into a Cambridge cybersecurity startup that's full of spies
This week, a relatively young cybersecurity company called Darktrace announced that it has raised an additional 65 million ( 50 million) at a suspected valuation of over 400 million ( 308 million). No other UK tech startup has announced a funding round anywhere near that size since the UK voted for Brexit. We caught up with Mike Lynch -- the billionaire founder of enterprise software firm Autonomy and Darktrace's first big name investor -- to find out why he decided to put his money into the company. "The reason I liked it was that it was a completely new approach," said Lynch during a phone call with Business Insider on Wednesday. "Most of what's out there in cybersecurity is based on knowing what you're looking. So things like anti-virus and that sort of stuff or trying to build a big wall around the outside of your company, a boundary. "The problem is that the world's moved on and the attacks no longer have signatures.
Deep learning applied to drug discovery and repurposing
In a recently accepted manuscript titled "Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data", scientists from Insilico Medicine, Inc located at the Emerging Technology Centers at Johns Hopkins University in collaboration with Datalytic Solutions and Mind Research Network presented a novel approach applying deep neural networks (DNNs) to predict pharmacologic properties of many drugs. In this study, scientists trained deep neural networks to predict the therapeutic use of a large number of drugs using gene expression data obtained from high-throughput experiments on human cell lines. Authors used a sophisticated approach of measuring the differential signaling pathway activation score for a large number of pathways to reduce the dimensionality of the data while retaining biological relevance and used these scores to train the deep neural networks. "The world of artificial intelligence is rapidly evolving and affecting every aspect of our daily life. And soon this progress will be felt in the pharmaceutical industry. We set up the Pharma.AI division to help pharmaceutical companies significantly accelerate their R&D and increase the number of approved drugs, but in the process we came up with over 800 strong hypotheses in oncology, cardiovascular, metabolic and CNS space and started basic validation. We are cautious about making strong statements, but if this approach works, it will uberize the pharmaceutical industry and generate unprecedented number of QALY", said Alex Zhavoronkov, PhD, CEO of Insilico Medicine, Inc.
AI startup Findo.io raises another 4 million and introduces Predictive Insights
"Flint seeks to invest in ground-breaking technologies that directly improve human life," said Flint Capital Partner Artem Burachenok. "Findo's ability to mitigate the growing challenge of massive data in everyone's inbox, cloud and storage solution is a game changer." Findo's smart search engine helps users quickly find information buried in a wide array of documents, slides, audio files, images, or any other information from sources as varied as Dropbox, Google Drive, Evernote and Gmail, Exchange and Outlook. Findo search bots can search from Slack, Telegram, Facebook Messenger and Skype and deliver results right to the messenger. "We are excited to have Flint as one of our investors," said Gary A. Fowler, Co-Founder and CEO of Findo.
Siri, What Do You Most Often Help With? - eMarketer
Artificial intelligence (AI) assistants, like Apple's Siri and Microsoft's Cortana, can help internet users with a variety of activities, especially when they're on the go. According to June 2016 research, nearly two-thirds of AI users in the US use these personal assistants to answer general questions. San Francisco, CAโbased AYTM Market Research surveyed 1,000 US internet users about their dealings with an AI assistant. Overall, 58% had never used one, while about a quarter used AI assistants on at least a monthly basis. According to the survey, the majority (64.5%) of AI users said they used AI assistants to ask general questions, followed by getting directions while driving (39.7%) and making calls (25.2%). Other research confirms, though, that few mobile phone owners in the US actually use a voice-controlled personal assistant regularly.
Artificial Intelligence (AI) & Machine Learning Market in Big Data and IoT Industry Outlook and 2016-2021 Forecasts Research Report
More than 50% of enterprise IT organizations are experimenting with Artificial Intelligence (AI) in various forms such as Machine Learning, Deep Learning, Computer Vision, Image Recognition, Voice Recognition, Artificial Neural Networks, and more. AI is not a single technology but a convergence of various technologies, statistical models, algorithms, and approaches. Machine Learning is a sub-field of computer science that evolved from the study of pattern recognition and computational learning theory in AI. Companies covered in the Artificial Intelligence and Machine Learning Market report are: Amazon, AOL, Apple, Augury Systems, Baidu, C-B4, Comfy, Facebook, FocusMotion, Glassbeam, Google, H2O.ai, IBM, Imagimob, Inbenta, Intel, Maana, Microsoft, mnubo, MoBagel, Moov, Neura, NVIDIA, OpenAI, PointGrab, Salesforce, Sentenai, Sentrian, Skype, SparkCognition, Tachyus, Tellmeplus, Tesla, Twitter, Veros Systems, x.ai, and Yahoo. Every large corporation collects and maintains a huge amount of human-oriented data associated with its customers including their preferences, purchases, habits, and other personal information.
TrueCare24 Unveils Artificial Intelligence-Driven Healthcare Platform
TrueCare24 is pleased to unveil Baymax, an artificial intelligence messenger bot that quickly arranges medical services for users. According to Leo Popov, "We all struggle with balancing our busy lives and the things that matter the most: family, friends, and professional passions, and wasted time is especially frustrating. When you or a family member get sick, you've got to go through the hurdles of traditional healthcare, and it's just not practical for working professionals who also have families. Baymax is a personal healthcare companion that saves users precious time and money. It chooses and arranges a doctor's appointment that fits your schedule and budget. Baymax is superbly convenient for the '140 characters' lifestyle of today."